EN DE
Data-driven stock valuation

Lotte Chemical Titan Tbk PT (FPNI) fair value: what the stock is really worth

We calculate from audited financials what Lotte Chemical Titan Tbk PT is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.

  1. Compare price with fair valuebelow fair value = cheap, above = expensive
  2. Check the quality50 and up solid, 75 and up strong
  3. Watch it or check another stockalert when fair value or trend changes

Basic Materials · ID · Market cap 1.8T IDR (≈ $184M) · ISIN ID1000083801

At a glance

LC Lotte Chemical Titan Tbk PT FPNI · JK
Price570.00 IDR
Fair Value226.14 IDR
Upside−60.3%
Quality68/100

A solid business, but trading 152% above our fair value of 226.14 IDR.

As of Sep 8, 2026, the fair value of Lotte Chemical Titan Tbk PT is 226.14 IDR per share against a price of 570.00 IDR, so the fair value sits 60% below the price. A model estimate from reported figures, not an analyst target.

!Weak Growth (revenue 5y +0.5 %/yr)
!Thin margins · 2.3% net margin
Low debt · generates free cash flow
!Trails peers (5/14)
!Narrow moat 28/100
!Evidence only low, so the estimate is less certain
!Weak on past: 29 out of 100
!Weak on dividend: 6 out of 100
Evidence: Low Range 169.61 IDR to 282.68 IDR

Fair value as of: Sep 8, 2026

From 18 valuation models · updated yesterday

Fair value updated Sep 8, 2026, revised from 0.0100 IDR to 226.14 IDR (+2,261,300.0%) since Aug 13, 2026. Share price +33.8% over the past month.

Watch Lotte Chemical Titan Tbk PT for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits above even our optimistic bull case (282.68 IDR). The favourable scenario is already priced in.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • Solid but not exceptional quality (68/100) and above fair value, neither a clear bargain nor a standout compounder.

Price vs Fair Value (5 years)

1,725 IDR 141.00 IDR Fair Value 226.14 IDR Mar 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 8, 2026.

How to read this chart

60‑month range 141.00 IDR – 1,725 IDR · fair‑value band 169.61 IDR – 282.68 IDR · the 570.00 IDR price screens above the 226.14 IDR fair value. Dashed = 300-day average. As of Sep 8, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Lotte Chemical Titan Tbk PT (FPNI) currently trades at 570.00 IDR, while our model-based Fair Value estimate is 226.14 IDR, implying the stock looks roughly 152.1% overvalued today. The Quality Score stands at 68/100 (solid quality), in the Basic Materials sector. Bull case: the Growth DCF group reads highest at a median of 1,809 IDR per share, and 11 of the 18 models we run sit above the 570.00 IDR price. Bear case: the Earnings-Based group reads lowest at 226.14 IDR, and 7 of the 18 models stay below the price. Evidence for this calculation is low.

Over the trailing twelve months, Lotte Chemical Titan Tbk PT generated revenue of $315M at a net margin of 2.3%. Revenue declined 6.2% year over year. It earns a return on equity of 7.4%. The balance sheet holds a net cash position of $39.5M. Fundamentals as of Sep 8, 2026

Scenario range: 169.61 IDR (bear) to 282.68 IDR (bull), the price of 570.00 IDR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades about 71% below its 52-week high and 211% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at −57% fair-value upside, at −60%, FPNI screens richer than that median.

Fair Value models

Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then (16.95 IDR per share) are deliberately not added.

Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF best evidence 1,357 IDR 1,809 IDR 2,940 IDR 80
Growth DCF 1,357 IDR 2,035 IDR 2,940 IDR 78
Owner Earnings 452.28 IDR 678.42 IDR 904.56 IDR 77
All 18 models by family
DCF Models
FCF DCF best evidence 1,357 IDR 1,809 IDR 2,940 IDR 80
Owner Earnings 452.28 IDR 678.42 IDR 904.56 IDR 77
5Y Revenue Exit 1,131 IDR 1,809 IDR 2,488 IDR 72
5Y P/E Exit 678.42 IDR 678.42 IDR 904.56 IDR 72
10Y Revenue Exit 1,131 IDR 1,809 IDR 2,261 IDR 67
10Y P/E Exit 904.56 IDR 1,131 IDR 1,131 IDR 65
Earnings-Based
Graham-Dodd 226.14 IDR 226.14 IDR 226.14 IDR 67
Dividend Discount
Gordon GGM 171,414 IDR 224,557 IDR 280,187 IDR 69
DDM Multi-Stage 171,414 IDR 237,447 IDR 320,667 IDR 67
Multiples
P/E Multiple 226.14 IDR 226.14 IDR 452.28 IDR 60
P/S Multiple 226.14 IDR 226.14 IDR 452.28 IDR 55
P/B Multiple 226.14 IDR 226.14 IDR 452.28 IDR 52
EV/Revenue 1,131 IDR 1,583 IDR 2,261 IDR 53
Asset-Based
NCAV (Graham) 226.14 IDR 226.14 IDR 452.28 IDR 52
Growth DCF
Growth DCF 1,357 IDR 2,035 IDR 2,940 IDR 78
Rev-Margin DCF 1,131 IDR 1,809 IDR 2,488 IDR 72
Economic Profit
Residual Income 226.14 IDR 226.14 IDR 226.14 IDR 76
Growth Earnings
Growth-Adj P/E 226.14 IDR 226.14 IDR 226.14 IDR 68

Widest divergence: Dividend Discount (224,557 IDR) versus Earnings-Based (226.14 IDR). Highest evidence: FCF DCF (80).

Notify me when FPNI reaches fair value

Put FPNI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 10.5 as of Jun 9, 2026
P/S ratio 0.14 P/E × margin
EPS (TTM) 24.78 IDR price ÷ EPS = P/E 10.5
Dividend yield 0.3% payout 7.0%
Net margin 1.3% FY2025
Return on equity 7.4% TTM
More key figures
Profitability
Return on assets (EBIT) −2.1% avg 5y
Operating margin 1.3% TTM
Growth
Revenue (TTM) $315M TTM
Revenue growth (YoY) −6.2% 3y avg −12.6%
EPS growth (YoY) +152%
Balance sheet & cash flow
Free cash flow $30.5M FY2025
Net cash $39.5M FY2025

Figures from reported company fundamentals · as of Sep 8, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 68/100

Of which business quality 69 · Market factors (momentum, volatility) 71

Profitability 35
Margins and returns on capital today
Quality Growth 48
Are margins and returns improving?
Cashflow 72
Earnings quality: real cash, not paper profit
Fin. Strength 89
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 91
Price trend over the last 3–12 months (market factor)
52W Momentum 61
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

PT Lotte Chemical Titan Tbk, together with its subsidiaries, engages in the production and distribution of polyethylene products in Indonesia.

Full company description

PT Lotte Chemical Titan Tbk, together with its subsidiaries, engages in the production and distribution of polyethylene products in Indonesia. The company produces linear low density polyethylene resins used in film, wire and cable, rotational molding, and others extrusion applications; high density polyethylene resins used in injection and blow molding, extrusion, and film applications; low density polyethylene with applications, including food packaging films, heavy duty bags, injection molded articles, crates, industrial pails, chicken cages, dustbins, and container lids; and polypropylene homopolymers, and polypropylene random and impact copolymers, as well as BOPP films. It also involved in the trading and importation of polyethylene and polypropylene, as well as wholesale trading of rubber and plastics in basic form. The company was formerly known as P.T. Titan Kimia Nusantara Tbk and changed its name to PT Lotte Chemical Titan Tbk in April 2013. PT Lotte Chemical Titan Tbk was incorporated in 1987 and is headquartered in Jakarta, Indonesia. PT Lotte Chemical Titan Tbk operates as a subsidiary of Lotte Chemical Titan International Sendirian Berhad.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Lotte Chemical Titan Tbk PT reported revenue of $317M in FY2025 versus $412M in FY2021, a compound −6.4%/yr. Reported net income was $4.2M in FY2025, compounding −18.6%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$317M
Latest YoY
−13.9%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−12.6%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+0.5%
Avg. revenue growth/yr (23Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−24.7%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
−14.9%
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share−15.2%
Dividend yield0.3%
Trend Two data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5Y −15.2% vs 10Y 5.0%, flattening
Operating margin (EBIT) Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−2.9% (2020) → −2.6% (2025) · steady
Worst earnings drop451% (2024) (loss year, drop beyond 100%) · in USD
⚠ Revenue per share shrinking 4.6%/yr over ~10Y (margin trend unclear) Structural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Revenue −6.4%/yr
FY21 $412M
FY22 $474M
FY23 $376M
FY24 $368M
FY25 $317M
Net income −18.6%/yr
FY21 $9.6M
FY22 $2.9M
FY23 −$399K
FY24 −$8.3M
FY25 $4.2M

FPNI screens 152% overvalued. Compare with Linde plc →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lotte Chemical Titan Tbk PT Fair Value". https://www.fairvalue-calculator.com/stock/FPNI

Peer Group

Specialty Chemicals · 702 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation
Quality Score 68 · Top 25%
Profitability
Return on equity (TTM) 7% · Above median
Return on assets −2% · Bottom 25%
Net margin (TTM) 2% · Below median
Operating margin (TTM) 1% · Bottom 25%
Growth and dividend
Revenue growth −6% · Bottom 25%
Dividend yield (TTM) 0.3% · Bottom 25%
Balance sheet
Debt / equity 0.22× · Above median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 10.5× · Cheapest 25%
P/B 1.79× · Cheaper than median
P/S (TTM) 0.58× · Cheaper than median
P/FCF 6.0× · Pricier than median
EV/EBITDA 65.5× · Priciest 25%

What the price implies (reverse DCF)

The inverse question: what free-cash-flow growth must Lotte Chemical Titan Tbk PT deliver for ten years so that today's price is fair in our DCF model? Same formula, same discount rate as the fair value.

Implied FCF growth, 10 years+5.3 % per year
Achieved revenue growth, 5 years+0.5 % p.a.
Sector median revenue growth+3.4 %
FCF yield on price9.61 %
Discount rate (WACC) in the models15.0 %

The price demands an acceleration versus past growth: a high bar the company still has to clear. Ranking of the largest stocks →

Context: sector, industry, market

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 0
FUTURE0 · sector 21
PAST29 · sector 23
HEALTH89 · sector 95
DIVIDEND6 · sector 28

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Sep 8, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $477.57 $222.03 −54%
The Sherwin-Williams Company SHW $333.71 $143.38 −57%
Ecolab Inc ECL $279.28 $96.18 −66%
Air Products and Chemicals, Inc APD $301.27 $122.14 −59%
Givaudan SA GIVN CHF 3,237 CHF 1,498 −54%
Wanhua Chemical Group 600309 ¥77.66 ¥68.03 −12%
500820 500820 ₹2,757 ₹557.43 −80%
Sika AG SIKA CHF 189.55 CHF 98.89 −48%
Novozymes A/S NSISB kr 456.40 kr 169.99 −63%
Asian Paints Limited ASIANPAINT ₹2,630 ₹696.23 −74%

Compare Lotte Chemical Titan Tbk PT with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Frequently asked questions

Is Lotte Chemical Titan Tbk PT (FPNI) overvalued or undervalued?
As of Sep 8, 2026, our model estimates a fair value of 226.14 IDR versus a price of 570.00 IDR, about −60% upside (overvalued).
What is the fair value of FPNI?
Our model-based fair value for Lotte Chemical Titan Tbk PT is 226.14 IDR (as of Sep 8, 2026), built from audited fundamentals. The current price: 570.00 IDR.
What is the quality score of FPNI?
Lotte Chemical Titan Tbk PT has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lotte Chemical Titan Tbk PT (FPNI)?
Our model-based price target is the fair value of 226.14 IDR (as of Sep 8, 2026) from 18 valuation models. Cautious scenario 169.61 IDR, optimistic scenario 282.68 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Lotte Chemical Titan Tbk PT stock forecast for 2026?
Our models put fair value at 226.14 IDR, about −60% upside versus a price of 570.00 IDR (overvalued). Cautious scenario 169.61 IDR, optimistic scenario 282.68 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Lotte Chemical Titan Tbk PT (FPNI)?
Lotte Chemical Titan Tbk PT reported trailing-twelve-month revenue of about $315M (latest available figure, as of Sep 8, 2026).
What is the net profit margin of FPNI?
The net profit margin of Lotte Chemical Titan Tbk PT is about 2.3%, meaning it keeps roughly 2.3% of revenue as net income. Based on the latest reported figures.
Does Lotte Chemical Titan Tbk PT pay a dividend?
Lotte Chemical Titan Tbk PT currently shows a dividend yield of about 0.30% relative to its recent price (as of Sep 8, 2026).
What growth is priced into Lotte Chemical Titan Tbk PT (FPNI)?
For today's price to be fair in a discounted-cash-flow model, Lotte Chemical Titan Tbk PT would have to grow free cash flow by +5.3 % per year for ten years (discount rate 15.0 %, then 2 % perpetual growth). Over the last 5 years revenue grew +0.5 % per year. As of Sep 8, 2026.
What discount rate (WACC) does the fair value of FPNI use?
Our models discount Lotte Chemical Titan Tbk PT at 15.0 %: a base by market capitalisation (micro), country premium for Indonesia. The same rate applies in all 26 models.
What is the intrinsic value of Lotte Chemical Titan Tbk PT (FPNI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lotte Chemical Titan Tbk PT it is 226.14 IDR per share (as of Sep 8, 2026), against a price of 570.00 IDR. It is the blended result of 18 valuation models (cash flow, earnings, asset, dividend).
Is Lotte Chemical Titan Tbk PT stock overvalued or undervalued in 2026?
As of Sep 8, 2026, FPNI trades above its calculated fair value: price 570.00 IDR, fair value 226.14 IDR, a gap of about −60% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FPNI?
No. The price is what the market pays today (570.00 IDR); the fair value is what the company's own numbers justify (226.14 IDR). For Lotte Chemical Titan Tbk PT the two are 343.86 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Lotte Chemical Titan Tbk PT worth?
The market values Lotte Chemical Titan Tbk PT at about 1.8T IDR (market capitalisation, as of Sep 8, 2026). Per share that is 570.00 IDR; our models calculate a fair value of 226.14 IDR per share.
What do the bullish and bearish scenarios say about FPNI?
Our models span a range for Lotte Chemical Titan Tbk PT: cautious scenario 169.61 IDR, base 226.14 IDR, optimistic 282.68 IDR per share (as of Sep 8, 2026, price 570.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of FPNI?
Lotte Chemical Titan Tbk PT trades at a price-to-earnings ratio of 10.5 (as of Sep 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 226.14 IDR is built from several models across several years. Other multiples: P/B 1.8, P/S 0.6, EV/EBITDA 65.5.
How solid is the balance sheet of Lotte Chemical Titan Tbk PT (FPNI)?
Balance-sheet figures for Lotte Chemical Titan Tbk PT (as of Sep 8, 2026): return on equity 7.4%, debt of 0.22 per unit of equity. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is FPNI from its 52-week high?
Lotte Chemical Titan Tbk PT trades at 570.00 IDR, about 71% below its 52-week high of 1,955 IDR and 211% above the low of 183.00 IDR (as of Sep 8, 2026). Distance from the high says nothing about value: that is what the fair value of 226.14 IDR is for.
Which stocks are comparable to Lotte Chemical Titan Tbk PT?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lotte Chemical Titan Tbk PT stock attractive at the current price?
The data as of Sep 8, 2026: price 570.00 IDR, calculated fair value 226.14 IDR (−60%), Quality Score 68/100, from 18 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FPNI calculated?
We run Lotte Chemical Titan Tbk PT through 18 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 226.14 IDR, with the spread shown as a cautious and an optimistic scenario.
Free · no account needed

Watch Lotte Chemical Titan Tbk PT in the live analysis

One click puts Lotte Chemical Titan Tbk PT on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.